Brief: Alvotech and Teva Secure U.S. Settlement Date For AVT06
19/12/2025 08:39
Dec 19 (Reuters) - Alvotech SA ALVO.O: ALVOTECH AND TEVA SECURE U.S. SETTLEMENT DATE FOR AVT06, A PROPOSED BIOSIMILAR TO EYLEA® ALVOTECH SA - LICENSE ENTRY DATE FOR AVT06 IN U.S. SET FOR Q4 2026 Source text: ID:nGNXbmfQ1S Further company coverage: ALVO.O ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alvotech SA
See all newsBrief: CMS Announces Selection Of Drugs For Third Cycle Of The Medicare Drug Price Negotiation Program
Brief: Alvotech and Teva Secure U.S. Settlement Date For AVT06
India's Dr Reddy's rises after EU marketing authorisation for osteoporosis biosimilar
Brief: UK High Court Rules In Favor Of Alvotech Paving Way For AVT06, Biosimilar To Eylea
U.S. STOCKS ON THE MOVE-Cummins, EPAM Systems, Qualcomm